Honkamp Krueger Financial Services »

Vir Biotechnology shares owned by Honkamp Krueger Financial Services

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Honkamp Krueger Financial Services from 13F filings

Historical chart of Honkamp Krueger Financial Services investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Honkamp Krueger Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Honkamp Krueger Financial Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $520k 51k 10.13

More positions owned by Honkamp Krueger Financial Services

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Spdr Ser Tr Nuveen Bloomberg (HYMB)
Spdr Index Shs Fds Msci Acwi Exus (CWI)
First Tr Exch Traded Fd Iii Managd Mun Etf (FMB)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Core Msci Emkt (IEMG)
Alps Etf Tr Intl Sec Dv Dog (IDOG)
Apple (AAPL)
Ishares Tr National Mun Etf (MUB)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Honkamp Krueger Financial Services

Top funds holding Vir Biotechnology

BlackRock
Vanguard Group
Baillie Gifford & Co
Citadel Advisors
Alliancebernstein
Morgan Stanley
Geode Capital Management
Bill & Melinda Gates Foundation
Bridgeway Capital Management
Bank of America Corporation
Citigroup
Barclays
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management

View all funds holding Vir Biotechnology